Asthma Management in the Era of the COVID-19 Pandemic


Posted: 2021-11-06 19:00:00
Review Indian J Pediatr . 2021 Nov 6. doi: 10.1007/s12098-021-03979-z. Online ahead of print. Affiliations Expand Affiliations 1 Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. 2 School of Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, India. 3 School of Medicine, University of Auckland, Auckland, New Zealand. 4 Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. 5 Department of Pediatric Respiratory Medicine, Starship Children's Hospital, Auckland, New Zealand. 6 Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. umakanth.katwa@childrens.harvard.edu. Item in Clipboard Review Timothy Klouda et al. Indian J Pediatr. 2021. Show details Display options Display options Format Indian J Pediatr . 2021 Nov 6. doi: 10.1007/s12098-021-03979-z. Online ahead of print. Affiliations 1 Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. 2 School of Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, India. 3 School of Medicine, University of Auckland, Auckland, New Zealand. 4 Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. 5 Department of Pediatric Respiratory Medicine, Starship Children's Hospital, Auckland, New Zealand. 6 Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. umakanth.katwa@childrens.harvard.edu. Item in Clipboard CiteDisplay options Display options Format Abstract Asthma is common in children and exacerbations are usually triggered by respiratory viruses. There was considerable concern about the impact of COVID-19 on children with asthma. It was expected that children with asthma would fare poorly during the pandemic. However, the reported effect of the COVID-19 pandemic on pediatric asthma including acute asthma admissions, does not appear to be significant, but this needs careful follow-up. The socioeconomic effects of the pandemic and reduced healthcare access could potentially impact on ongoing delivery of health care in chronic respiratory conditions including asthma, especially in resource-poor settings. Children with chronic asthma need to be treated as per internationally published guidelines with innovative models of disease monitoring and ongoing care during the pandemic. During the pandemic, children with acute asthma need to be managed carefully based on local guidelines and using strict infection control policies. The use of technology such as telehealth and various tools of asthma management including questionnaires and digital monitoring will play an important role in asthma management during the pandemic. Medical professionals, healthcare administrators, and governments should be sensitive to the evolving needs of the community and work closely to continue to provide services in a challenging yet unresolved pandemic. Keywords: Asthma; COVID-19; Children; Pandemic; Socioeconomic; Telehealth. © 2021. Dr. K C Chaudhuri Foundation. References GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5:691–706. Ferrante G, La Grutta S. The burden of pediatric asthma. Front Pediatr. 2018;6:186. - DOI Ding Y, Yan H, Guo W. Clinical characteristics of children with COVID–19: a meta-analysis. Front Pediatr. 2020;8:431. - DOI Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39:355–68. - DOI Jat KR, Sankar J, Das RR, et al. Clinical profile and risk factors for severe disease in 402 children hospitalized with SARS–CoV–2 from India: Collaborative Indian Pediatric COVID Study Group. J Trop Pediatr. 2021;67:fmab048. Show all 39 references Publication types [x] Cite Copy Format: Send To [x]

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
8月 05, 2020 バイオアソシエイツ

コウモリのウイルス耐性と長寿命が、新型コロナウイルスへのヒントを提供するとの展望が発表された

コウモリは、ヒトに影響を与える多くの致命的なウイルス(エボラ出血熱、狂犬病、そして最近では COVID-19 を引き起こすコロナウイルスのSARS-CoV-2など)に対し、耐性があると考えられている。 ヒトはこれらの病原体で有害な症状を経験するが、コウモリはウイルスに著しく耐えることができ、さらに、同じサイズの陸上哺乳類よりもはるかに長く生きる。コウモリの寿命とウイルス耐性の秘密は何か?…

ゲスト 585人 と メンバー 2人 がオンラインです